These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2888801)

  • 1. A comparative study of metronidazole and sulfasalazine in active, not severe, ulcerative colitis. An Israeli multicenter trial.
    Gilat T; Suissa A; Leichtman G; Delpre G; Pavlotzky M; Grossman A; Fireman Z
    J Clin Gastroenterol; 1987 Aug; 9(4):415-7. PubMed ID: 2888801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of metronidazole and sulfasalazine in the maintenance of remission in patients with ulcerative colitis.
    Gilat T; Leichtman G; Delpre G; Eshchar J; Bar Meir S; Fireman Z
    J Clin Gastroenterol; 1989 Aug; 11(4):392-5. PubMed ID: 2569488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
    Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
    Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metronidazole in Crohn's disease.
    Gilat T
    Gastroenterology; 1982 Sep; 83(3):702-4. PubMed ID: 6124478
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective, randomized, double-blind comparison of benzalazine and sulfasalazine in the treatment of active ulcerative colitis.
    Fleig WE; Laudage G; Sommer H; Wellmann W; Stange EF; Riemann J
    Digestion; 1988; 40(3):173-80. PubMed ID: 2906888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is continuous sulfasalazine necessary in the management of patients with ulcerative colitis? Results of a preliminary study.
    Dickinson RJ; King A; Wight DG; Hunter JO; Neale G
    Dis Colon Rectum; 1985 Dec; 28(12):929-30. PubMed ID: 2866071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. I. Design and methodologic considerations.
    Rosén A; Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O
    Gastroenterology; 1982 Sep; 83(3):541-9. PubMed ID: 6124473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ulcerative colitis with olsalazine and sulphasalazine: efficacy and side-effects.
    Ewe K; Eckardt V; Kanzler G
    Scand J Gastroenterol Suppl; 1988; 148():70-5. PubMed ID: 2906479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial.
    Meyers S; Sachar DB; Present DH; Janowitz HD
    Gastroenterology; 1987 Dec; 93(6):1255-62. PubMed ID: 2890550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind comparison of olsalazine and sulphasalazine in active ulcerative colitis.
    Willoughby CP; Cowan RE; Gould SR; Machell RJ; Stewart JB
    Scand J Gastroenterol Suppl; 1988; 148():40-4. PubMed ID: 2906476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis.
    Mulder CJ; Tytgat GN; Weterman IT; Dekker W; Blok P; Schrijver M; van der Heide H
    Gastroenterology; 1988 Dec; 95(6):1449-53. PubMed ID: 2903110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind comparative study of sulfasalazine and controlled-release mesalazine tablets in the treatment of active ulcerative colitis.
    Munakata A; Yoshida Y; Muto T; Tsuchiya S; Fukushima T; Hiwatashi N; Kobayashi K; Kitano A; Shimoyama T; Inoue M
    J Gastroenterol; 1995 Nov; 30 Suppl 8():108-11. PubMed ID: 8563868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.
    Klotz U; Maier K; Fischer C; Heinkel K
    N Engl J Med; 1980 Dec; 303(26):1499-502. PubMed ID: 6107853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute ulcerative colitis--a rare complication of sulfasalazine therapy.
    Ruppin H; Domschke S
    Hepatogastroenterology; 1984 Aug; 31(4):192-3. PubMed ID: 6148297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse-preventing effect and safety of sulfasalazine and olsalazine in patients with ulcerative colitis in remission: a prospective, double-blind, randomized multicenter study. The Ulcerative Colitis Multicenter Study Group.
    Rijk MC; van Lier HJ; van Tongeren JH
    Am J Gastroenterol; 1992 Apr; 87(4):438-42. PubMed ID: 1348159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis.
    Chapman RW; Selby WS; Jewell DP
    Gut; 1986 Oct; 27(10):1210-2. PubMed ID: 3536677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic effect of methyl-salazosulphapyridine versus salazosulphapyridine in active ulcerative colitis. A double-blind controlled trial.
    Riis P; Jarnum S; Holtz A; Folkenborg O; Kristensen M; Binder V
    Scand J Gastroenterol; 1979; 14(6):647-51. PubMed ID: 43585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Andoh A; Tsujikawa T; Fujiyama Y; Mitsuyama K; Sata M; Yamada M; Iwaoka Y; Kanke K; Hiraishi H; Hirayama K; Arai H; Yoshii S; Uchijima M; Nagata T; Koide Y
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1502-6. PubMed ID: 17101300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olsalazine versus sulfasalazine in mild to moderate childhood ulcerative colitis: results of the Pediatric Gastroenterology Collaborative Research Group Clinical Trial.
    Ferry GD; Kirschner BS; Grand RJ; Issenman RM; Griffiths AM; Vanderhoof JA; Fiedorek SC; Winter HS; Hassall EG; Watkins JB
    J Pediatr Gastroenterol Nutr; 1993 Jul; 17(1):32-8. PubMed ID: 8102399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.